The p66Shc expression in PCa is often upregulated in response to androgens, the primary hormones driving PCa growth, through androgen receptor (AR) signalling pathways, and creates a microenvironment conducive to tumour growth [117, 118]. The gene discussed is AR; the disease is neoplasm.